Skip to content
drillr.ai
Sign up

LSTA

Lisata Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$1.65
+0.61%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue100.0K170.0K1.0M——
Cost of Revenue5.0K146.0K———
Gross Profit95.0K24.0K1.0M——
Operating Expenses
R&D Expense4.9M7.9M11.3M12.7M43.5M
SG&A Expense11.6M10.4M12.1M13.0M14.1M
General & Admin Expense11.6M10.4M12.1M13.0M14.1M
Selling & Marketing Expense—————
Other Expenses—(146.0K)———
Total Operating Expenses16.5M18.2M23.4M25.7M57.6M
Cost and Expenses16.5M18.4M23.4M25.7M57.6M
Operating Income (EBIT)(16.4M)(18.2M)(22.4M)(25.7M)(57.6M)
Non-Operating
Interest Income199.0K806.0K1.9M2.7M1.1M
Interest Expense—————
Net Interest Income199.0K806.0K1.9M2.7M1.1M
Other Non-Op Income/Expense1.4M661.0K1.6M2.5M897.0K
Non-Operating Income (excl Interest)(356.0K)(661.0K)(1.6M)(2.5M)(897.0K)
EBT (Pre-Tax Income)(15.0M)(17.5M)(20.8M)(23.2M)(56.7M)
Income Tax Expense(387.0K)(962.0K)(798.0K)(2.3M)(2.5M)
Bottom Line
Net Income(14.6M)(16.6M)(20.0M)(20.8M)(54.2M)
Earnings from Cont. Ops(14.6M)(16.6M)(20.0M)(20.8M)(54.2M)
Earnings from Discont. Ops—————
Bottom Line Net Income(14.6M)(16.6M)(20.0M)(20.8M)(54.2M)
Per Share
Basic EPS($1.64)($1.91)($2.40)($2.58)($10.47)
Diluted EPS($1.64)($1.91)($2.40)($2.58)($10.47)
Revenue Per Share$0.01$0.02$0.12$0.00$0.00
Shares
Basic Shares Outstanding9.1M8.7M8.3M8.1M5.2M
Diluted Shares Outstanding9.1M8.7M8.3M8.1M5.2M
Profitability Metrics
EBITDA(16.0M)(17.4M)(20.6M)(23.0M)(56.6M)
D&A64.0K146.0K174.0K189.0K69.0K
EBIT(16.1M)(17.5M)(20.8M)(23.2M)(56.7M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026